Tower Research Capital (TRC)’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-5,575
| Closed | -$51K | – | 6590 |
|
|
2021
Q2 | $51K | Buy |
5,575
+2,819
| +102% | +$16.4K | ﹤0.01% | 3019 |
|
|
2021
Q1 | $14K | Sell |
2,756
-7,458
| -73% | -$36K | ﹤0.01% | 4187 |
|
|
2020
Q4 | $44K | Sell |
10,214
-33,423
| -77% | -$136K | ﹤0.01% | 3245 |
|
|
2020
Q3 | $188K | Buy |
43,637
+35,429
| +432% | +$148K | ﹤0.01% | 2634 |
|
|
2020
Q2 | $37K | Buy |
8,208
+7,587
| +1,222% | +$33.9K | ﹤0.01% | 3297 |
|
|
2020
Q1 | $2K | Buy |
+621
| New | +$5.27K | ﹤0.01% | 2693 |
|
|
2019
Q4 | – | Sell |
-6,708
| Closed | -$46K | – | 4739 |
|
|
2019
Q3 | $46K | Buy |
+6,708
| New | +$49.2K | ﹤0.01% | 1859 |
|
|
2019
Q2 | – | Sell |
-625
| Closed | -$6K | – | 4592 |
|
|
2019
Q1 | $6K | Buy |
625
+389
| +165% | +$3.95K | ﹤0.01% | 3006 |
|
|
2018
Q4 | $3K | Buy |
236
+174
| +281% | +$2.19K | ﹤0.01% | 3269 |
|
|
2018
Q3 | $1K | Sell |
62
-9,609
| -99% | -$130K | ﹤0.01% | 3664 |
|
|
2018
Q2 | $103K | Buy |
9,671
+8,552
| +764% | +$83.4K | 0.01% | 1424 |
|
|
2018
Q1 | $10K | Buy |
+1,119
| New | +$9.82K | ﹤0.01% | 2480 |
|
|
2017
Q4 | – | Sell |
-3,266
| Closed | -$25K | – | 4248 |
|
|
2017
Q3 | $25K | Buy |
+3,266
| New | +$24.5K | ﹤0.01% | 2598 |
|
|
2017
Q2 | – | Sell |
-4,699
| Closed | -$33K | – | 3727 |
|
|
2017
Q1 | $33K | Buy |
4,699
+3,320
| +241% | +$20.8K | ﹤0.01% | 976 |
|
|
2016
Q4 | $6K | Buy |
+1,379
| New | +$6.67K | ﹤0.01% | 2991 |
|
|
2016
Q3 | – | Sell |
-1,455
| Closed | -$5K | – | 4782 |
|
|
2016
Q2 | $5K | Sell |
1,455
-3,578
| -71% | -$13.2K | ﹤0.01% | 3438 |
|
|
2016
Q1 | $17K | Sell |
5,033
-19,430
| -79% | -$68.6K | ﹤0.01% | 1489 |
|
|
2015
Q4 | $83K | Buy |
24,463
+21,420
| +704% | +$99.4K | 0.01% | 355 |
|
|
2015
Q3 | $16K | Buy |
3,043
+690
| +29% | +$4.25K | ﹤0.01% | 1945 |
|
|
2015
Q2 | $16K | Buy |
+2,353
| New | +$16.7K | ﹤0.01% | 2311 |
|
|
2015
Q1 | – | Sell |
-1,024
| Closed | -$8K | – | 5122 |
|
|
2014
Q4 | $8K | Buy |
+1,024
| New | +$8.69K | ﹤0.01% | 2378 |
|
|
2014
Q3 | – | Sell |
-100
| Closed | -$1.35K | – | 5060 |
|
|
2014
Q2 | $2K | Sell |
100
-402
| -80% | -$6.83K | ﹤0.01% | 3502 |
|
|
2014
Q1 | $9K | Sell |
502
-4,416
| -90% | -$84.2K | ﹤0.01% | 2744 |
|
|
2013
Q4 | $55K | Buy |
+4,918
| New | +$58.6K | 0.01% | 1304 |
|
Other funds holding KIN
Tower Research Capital (TRC)'s KIN Position: Q3 2021 in Review
Tower Research Capital (TRC) sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 5,575 shares — an estimated $51K sold.
Tower Research Capital (TRC) first reported a position in KIN in Q4 2013 and held it in 24 quarters. The position peaked at $188K in Q3 2020. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.
- Tower Research Capital (TRC) reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Tower Research Capital (TRC) sold 5,575 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $51K.
- Tower Research Capital (TRC) first reported a position in Kindred Biosciences, Inc. in Q4 2013 and held it in 24 quarters.
- Tower Research Capital (TRC)'s Kindred Biosciences, Inc. position peaked at $188K in Q3 2020.
- 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.